C.M. Bidwell & Associates’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-740
Closed -$13K 633
2021
Q1
$13K Sell
740
-3,980
-84% -$78.5K 0.01% 378
2020
Q4
$86K Sell
4,720
-18,435
-80% -$292K 0.07% 250
2020
Q3
$295K Buy
+23,155
New +$296K 0.27% 63
2016
Q2
Sell
-16,225
Closed -$247K 339
2016
Q1
$247K Buy
+16,225
New +$246K 0.06% 146

Other funds holding NXGN

C.M. Bidwell & Associates's NXGN Position: Q2 2021 in Review

C.M. Bidwell & Associates sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q2 2021, closing a stake of 740 shares — an estimated $13K sold.

C.M. Bidwell & Associates first reported a position in NXGN in Q1 2016 and held it in 4 quarters. The position peaked at $295K in Q3 2020. 164 funds tracked by Wall St. Rank hold NXGN as of Q2 2021.

  • C.M. Bidwell & Associates reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 740 NextGen Healthcare, Inc. Common Stock shares in Q2 2021, an estimated $13K.
  • C.M. Bidwell & Associates first reported a position in NextGen Healthcare, Inc. Common Stock in Q1 2016 and held it in 4 quarters.
  • C.M. Bidwell & Associates's NextGen Healthcare, Inc. Common Stock position peaked at $295K in Q3 2020.
  • 164 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q2 2021.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2021, filed 13 Aug 2021.